Bold Health aims to tackle numerous digestive conditions through digital therapeutic products
At Bold, we develop new technologies based on evidence-based research with the potential to improve patient wellbeing. We then conduct extensive clinical studies, including prospective randomized controlled trials, to evaluate our products so they can be confidently prescribed by doctors and used by patients.
|Discovery||Pilot||Clinical||CE Approved||FDA Approved||Academic Partner|
Irritable Bowel Syndrome (IBS)
Inflammatory Bowel Disease (IBD)
Gastroesophageal Reflux Disease (GERD)
Interested in our products?
If you’d like to learn more about any of our clinical trials underway, or you would like to explore a potential clinical trial collaboration please contact us. We’d love to hear from you.